Alphavirus vectors: Development and potential therapeutic applications

Expert Opinion on Biological Therapy

Volumn 1, Issue 2, 2001, Pages 177-191

  Schlesinger, Sondra ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alphavimses; Expression vectors; Forest vims; RNA vinises; Semliki; Sindbis vims; Vaccines; Venezuelan equine encephalitis; Vims detection assays

Indexed keywords

VIRUS RNA; VIRUS VACCINE;

ALPHA VIRUS; ANIMAL; ANTIBODY SPECIFICITY; DNA VECTOR; GENE THERAPY; GENETICS; HELPER VIRUS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; NEOPLASM; PATHOGENICITY; PHYSIOLOGY; REPLICON; REVIEW; VIRUS ASSEMBLY; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION;

ALPHAVIRUS; ANIMAL; GENE THERAPY; GENES, VIRAL; GENETIC VECTORS; GENOME, VIRAL; HELPER VIRUSES; HUMAN; NEOPLASMS; ORGAN SPECIFICITY; REPLICON; RNA, VIRAL; VIRAL VACCINES; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0035289225     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.1.2.177     Document Type: Article

References (80)

1. SCHLESINGER S, SCHLESINGER MJ: Togaviridae:the viruses and their replication. In: Togatiridae: tbe viruses and their replication. Fields BN, Knipe DM, Howley PMS (Eds.). Lippincott-Raven Philadelphia, Country (1996): 825-841
2. STRAUSS JH, STRAUSS EG: The alphavlruses: gene expression, replication and evolution. Microbiol. Rev. (1994) 58:491-562.
3. WANG K-S, SCHMALJOHN AL, KUHN RJ, STRAUSS JH: Antiidiotypic antibodies as probes for the Sindbis virus receptor. Virology (1991) 181:694-702.
4. WANG K-S, KUHN RJ, STRAUSS EG, OU S, STRAUSS JH: High-affinity laminin receptor is a receptor for Sindbis virus In mammalian cells. J Virol. (1992) 66:4992-5001.
5. BYRNES AP, GRIFFIN DE: Binding of Sindbis virus to cell surface heparan sulfate. J Virol. (1998) 72:7349-7356.
6. KLIMSTRA WB, RYMAN KD, JOHNSTON RE: Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol. (1998) 72:7357-7366.
7. OHNO K, SAWAI K, HJIMA Y, LEVIN B, MERUELO D: Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat. Biotecbnol. (1997) 15:763-767.
8. LEMM JA, RUMENAPF T, STRAUSS EG, STRAUSS JH, RICE CM: Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus and plus-strand RNA synthesis. EMBOJ.(1994) 13:2925-2934.
9. LEMM JA, BERGQVIST A, READ CM, RICE CM: Templatedependent initiation of Sindbis virus RNA replication in vitro. J. Virol. (1998) 72:6546-6553.
10. LEVIS R, SCHLESINGER S, HUANG HV: Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol. (1990) 64:1726-1733.
11. RAJUR, HUANG HV:Analysis of Sindbis virus promoter recognition In vii'o, using novel vectors with two subgenomic mRNA promoters. J. Virol. (1991) 65:2501-2510.
12. WEISS B, NITSCHKO H, GHATTAS I, WRIGHT R, SCHLESINGER S: Evidence for specificity in the encapsidation of Sindbis virus RNAs.J. Virol. (1989) 63:5310-5318.
13. FROLOVA E, FROLOV I, SCHLESINGER S: Packaging signals in alphaviruses. J Virol. (1997) 71:248-258.
14. FROLOV I, SCHLESINGER S: Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. J. Virol. (1994) 68:1721-1727.
15. LEVINE B, HUANG Q, ISAACS JT, REED JC, GRIFFIN DE, HARDWICK JM: Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (.1995) 361:739-742.
16. SCALLAN MF, ALLSOPP TE, FAZAKERLEY JK: Bcl-2 acts early to restrict Semlikl Forest virus replication and delays virus-induced programmed cell death. J Virol. (1997) 71:1583-1590.
17. XIONG C, LEVIS R, SHEN P, SCHLESINGER S, RICE CM, HUANG HV: Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science (1989) 243:1188-1191.
18. LILJESTRÖM P, GAROFF H: A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biol. Technology (1991) 9:1356-1361.
19. HERWEIJER H, LATENDRESSE JS, WILLIAMS P et al.-. A plasmld-based self-amplifying Sindbis virus vector. Hum. Gene Tbcr. (1995) 6:1161-1167.
20. DUBENSKY TWJ, DRIVER DA, POLO JM et al.: Sindbis virus DNA-based expression vectors: utility (or in vitro and in vivo gene transfer. J Virol. (1996) 70:508-519.
21. BREDENBEEK PJ, FROLOV I, RICE CM, SCHLESINGER S: Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. (1993) 67:6439-6446.
22. BERGLUND P, SJOBERG M, GAROFF H, ATKINS GJ, SHEAHAN BJ, LILJESTRÖM P: Semlikl Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (1993) 11:916-920.
23. DUBUISSON J, RICE CM: Sindbis virus attachment: isolation and characterization of mutants with impaired binding to vertebrate cells. J. Virol. (1993) 67:3363-3374.
24. FROLOV I, FROLOVA E, SCHLESINGER S: Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J. Viml. (1997) 71:2819-2829.
25. PUSHKO P, PARKER M, LUDWIG GV, DAVIS NL, JOHNSTON RE, SMITH JF: Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 239:389-401.
26. SMERDOU C, LILJESTRÖM P: Two-helper RNA system for production of recombinant Semliki Forest virus particles. J. Virol. (1999) 73:1092-1098.
27. POLO JM, BELU BA, DRIVER DA ct ah STable alphavirus packaging cell lines for Sindbis virus and Semlikl Forest virus-derived vectors. Proc. Natl. Acad. Sci. USA (1999) 96:4598-4603.
28. HAHN CS, HAHN YS, BRACIALE TJ, RICE CM: Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc. Natl. Acad. Sci. USA (1992) 89:2679-2683-
29. OLIVO PD, FROLOV I, SCHLESINGER S: A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand UNA viruses. Virology (.1994) 198:381-384.
30. AGAPOV EV, FROLOV I, LINDENBACH BD, PRAGAI BM, SCHLESINGER S, RICE CM: Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc. Natl. Acad. Set. USA (1998) 95:12989-12994.
31. LEVIS R, HUANG H, SCHLESINGER S: Engineered defective interfering RNAs of Sindbis virus express bacterial chloramphenicol acetyltransferase in avion cells. Proc. Natl. Acad. Sci. USA (1987) 84:4811-4815.
32. LONDON SD, SCHMALJOHN AL, DALRYMPLE JM, RICE CM: Infectious enveloped RNA virus antigenic chimeras. Proc. Natl. Acad. Sci. USA (1992) 89:207-211.
33. WEISS B, ROSENTHAL R, SCHLESINGER S: Establishment and maintenance of persistent infection by Sindbis virus in BHK cells. J Virol. (1980) 33:463-474.
34. DRYGA SA, DRYGA OA, SCHLESINGER S: Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene. Virology (1997) 228:74-83.
35. FROLOV I, AGAPOV E, HUFFMAN TA, Jr. et al: Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J Virol. (1999) 73:3854-3865.
36. PERR1 S, DRIVER DA, G ARDNER JP et al.-. Repllcon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells. J Virol. (2000) 74:9802-9807.
37. UBOL S, TUCKER PC, GRIFFIN DE, HARDWICK JM: Neurovirulent strains of Alphavirus induce apoptosis in bcl-2- expressing cells: role of a single amino acid change in the E2 giycoprotein. Proc. Natl. Acad. Sci. USA (1994) 91:5202-5206.
38. LANDIS H, SLMON-JODICKE A, KLOTI A et al.: Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. (1998) 72:1516-1522.
39. SCHLESINGER S, DUBENSKY TW: Alphavirus vectors for gene expression and vaccines. Curr. Opin. Biotcchnol. (1999) 10:434-439.
40. LUNDSTRO.M K: Alphaviruses as tools in neurobiology and gene therapy. J. Rcccpt. Signal Tiwisduct. Res. (1999) 19:673-686.
41. LUNDSTROM K: Alphaviruses as expression vectors. Curr. Opin. Biotccbnol. (1997) 8:578-582.
42. GAROFF H, LI KJ: Recent advances in gene expression using alphavirus vectors. Curr. Opln. Blotecbnol. (1998) 9:464-469.
43. FROLOV I, SCHLESINGER S: Translation of Sindbis virus niRNA: effects of sequences downstream of the Initiating codon. J. Virol. (199-4) 68:8111-8117.
44. FROLOV I, SCHLESINGER S: Translation of Sindbis virus niRNAj analysis of sequences downstream of the initiating AUG codon that enhance translation.J. Virol. (1996)70:1182-1190.
45. SJOBERG EM, SUOMALAINEN M, GAROFF H: A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Btotecbnology(.l994) 12:1127-1131.
46. SJOBERG E M, GAROFF H: The translation-enhancing region of the Semliki Forest virus subgenome is only functional in the virus-infected cell. J. Gen. Virol. (1996) 77:1323-1327.
47. STRONG TV, HAMPTON TA, LOURO I, BILBAO G, CONRY KM, CURIEL DT: Incorporation of beta-globin untranslated regions into a Sindbis virus vector for augmentation of heterologous mRNA expression. Gene Ther. (1997) 4:624-627.
48. BOORSMA M, NIEBA L, KOLLER D, BACHMANN MF, BAILEY JE, RENNER WA: A temperature-regulated repllcon-based DNA expression system. Nature Biolecbnol. (2000) 18:429-432. Design of a stable cell line in which a Sindbis virus replicon is induced by temperature and its use for producing protein.
49. JOHNSON B\X', OLSON KE, ALLEN-MIURA T et al.: Inhibition of luciferase expression in transgenic Aedes aegypti mosquitoes by Sindbis virus expression of antisense luciferasc RNA. Proc. Katl. Acad. Sci. USA (1999) 96:13399-13403. Demonstrates the potential of using Sindbis vectors to synthesise antisense RNAs. In this example the antisense RNA was able to inhibit expression of a gene inserted into the mosquito genome.
50. BLAIR CD, ADELMAN ZN, OLSON KE: Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes. Clin. Mtcrobiol. Rev. (2000) 13:651-661.
51. OLSON KE, HIGGS S, GAINESPJ et al.: Genetically engineered resistance to dengue-2 virus transmission in mosquitoes. Science W)0) 272:884-886.
52. HIGGS S, RAYNER JO, OLSON KE, DAVIS BS, BEATY BJ, BLAIR CD: Engineered resistance in Aedes aegypti to a West African and a South American strain of yellow fever virus. Am.J. Trop. Mcd. Hj-g. (1998) 58:663-670.
53. LEWIS DL, DECAMILLIS MA, BRUNETTI CR et al.: Ectopic gene expression and homeotic transformations in arthropods using recombinant Sindbis viruses. Curr. Biol. (1999) 9:1279-1287. Investigation of homeotic gene function in butterflies and beetle embryos using Sindbis virus vectors.
54. EHRENGRUBER MU, LUNDSTROM K, SCHWEITZER C, HEUSS C, SCHLESINGER S, GÄHW1LER BH: Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hlppocampal slice cultures. Proc. Kail. Acad. Set. USA (1999) 96:7041-7046.
55. MALETIC-SAVATIC M, MAUNOW R, SVOBODA K: Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science (1999) 283:1925-1927.
56. SH1 SH, HAYASHI Y, PETRA11A RS et al: Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science (1999) 284:1811-1816.
57. OSTEN P, K11ATRI L, FEREZ JL et al.-. Mutagenesis reveals a role for ABP/GRIP binding to GIuR2 in synaptic surface accumulation of the AMPA receptor. Neuron (2000) 27:313-325.
58. DAV1S ML, BROWN KW, JOHNSTON RE: A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Viral. (1996) 70:3781-3787.
59. MACDONA1D GH, JOHNSTON RE: Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J Virol. (2000) 74:914-922. Shows a correlation between virulence of VEE virus and te ability to target to murine dendritic cells.
60. GARDNER JP, FROLOV I, PERRI S et al.: Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein. J Virol. (2000) 74:11849-11857. dentifies mutations in the Sindbis virus E2 glycoprotein that greatly enhance the ability of the replicon particles to infect human dendritic cells.
61. BERGLUND P, SMERDOU C, FLEETON MM, TUBULEKAS I, LILJESTRÖM P: Enhancing immune responses using suicidal DNA vaccines. Nat. Blotecbnol. (1998) 16:562-565.
62. HARIHARAN MJ, DRIVER DA, TOWNSEND K et ah DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol. (1998) 72:950-958.
63. CHARLES PC, BROWN KW, DAVIS NL, HART MK, JOHNSTON RE: Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Virolog)' (1997) 228:153-160.
64. COLOMBAGE G, HALL R, PAVY M, LOBIGS M: DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 250:151-163.
65. TSUJI M, BERGMANN CC, TAKITA-SONODA Y et al.: Recombinant Sindbis viruses expressing a cytotoxic T-rymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen In mice. J. Virol. (1998) 72:6907-6910.
66. HEVEY M, NEGLEY D, PUSHKO P, SMITH J, SCHMALJOHN A: Marburg virus vaccines based upon alphavirus replacons protect guinea pigs and nonhuman primates. Virology (1998) 251:28-37.
67. BERGLUND P, QUESADA-ROLANDER M, PUTKONEN P, BIBERFELD G, THORSTENSSON R, LILJESTROM P: Outcome of Immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus Type 1 envelope protein and challenge with a high dose of SHW-4 virus. AIDS Res. Hum. RetroHruses (1997) 13:1487-1495.
68. MOSSMAN SP, BEX F, BERGLUND P et al: Protection against lethal simian immunodeficiency virus SrVsmmPBj 14 disease by a recombinant Semliki Forest virus gpl60 vaccine and by a gp120 subunit vaccine. J. Virol. (1996) 70:1953-1960.
69. DAV1S ML, CALEY IJ, BROWN KW et al.: Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol. (2000) 74:371-378.
70. IVANOVA L, SCHLESINGER S, OLIVO PD: Regulated expression of a Sindbis virus replicon by herpesvirus promoters. J. Virol. (1999) 73:1998-2005. Induction of a wild type Sindbis virus replicon and a prototype assay for detection of herpesviruses.
71. OLIVO PD, COLLINS PL, PEEPLES ME, SCHLESINGER S: Detection and quantitation of human respiratory syncytial virus (RSV) using minigenome cDNA and a Sindbis virus replicon: a prototype assay for negativestrand RNA viruses. Virology (1998) 251:198-205. Use of the non-cytopathic Sindbis virus replicon in design of a prototype assay for negative-strand RNA viruses.
72. KOLLER D, RUEDL C, LOETSCHER M et al.: A high-throughput functional expression cloning system for mammalian cells. (2001) Submitted.
73. YING H, ZAKS TZ, WANG RF étal.: Cancer therapy using a self-replicating RNA vaccine. Nat. Med. (1999) 5:823-827.
74. LEITNER WW, YING H, DRIVER DA, DUBENSKY TW, RESTIFO NP: Enhancement of tumor-specific immune response with plasmld DNA replicon vectors. Cancer Res. (2000) 60:51-55.
75. IIJ1MA Y, OHNO K, IKEDA H, SAWAI K, LEVIN B, MERUELO D: Cell-specific targeting of a thymidine kinase/ganciclovir gene therapy system using a recombinant Sindbis virus vector. Int.J. Cancer (1999) 80:110-118.
76. WAHLFORS JJ, ZULLO SA, LOIMAS S, NELSON DM, MORGAN RA: Evaluation of recombinant alphaviruses as vectors in gene therapy. Gene Tber. (2000) 7:472-480.
77. EHRENGRUBER M, HENNOU S, BÜELER H, NAIM H, LUNDSTROM K: Gene transfer into neurons from hippocampal slices by recombinant Semliki Forest virus, adenovirus, adeno-associated virus and measles virus. (2001) Submitted.
78. DICIOMMO DP, BREMNER R: Rapid, high level protein production using DNA-based Semliki Forest virus vectors.J. Blol. Cbem. (1998) 273:18060-18066.
79. CONNETT H: News. Nature Medicine (2000) 1199-1200.
80. LUNDSTROM K, BLASEY H, HOVIUS R, VOGEL H, BERNARD A: The Semliki Forest virus system: receptor expression and scale-up. Genetic Engineer and Biotechnologtst (1997) 17:101-106.